Home > Healthcare & Medical Devices > U.S. Cannabis Testing Market

U.S. Cannabis Testing Market Size By Technology (Chromatography {Liquid Chromatography, Gas Chromatography}, Spectroscopy {Mass Spectrometry, Atomic Spectroscopy}), By Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing), Industry Analysis Report, Zonal Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI4481
  • Published Date: Jan 2021
  • Report Format: PDF

Industry trends

U.S. Cannabis Testing Market size valued at USD 2 billion in 2020 and is estimated to grow at over 10.4% CAGR between 2021 and 2027. Increasing need of cannabis cultivators for testing and quality control of hemp products will spur the market growth.

U.S. Cannabis Testing Market

Get more details on this report - Request Free Sample PDF

Various organizations provide accreditation to U.S. cannabis testing laboratories that perform analytical testing of hemp and cannabis-derived products. As testing of cannabis products is required for demonstrating the safety and efficacy of the products, thus, the growing need of cannabis testing will boost the number of laboratories providing cannabis testing services.

In few states of U.S. such as California and New York, the activities of cannabis testing continued during the COVID-19 closure or lockdown. This was done to perform cannabis testing for medical use as well as for treatment of COVID-19. Moreover, the effectiveness of cannabis extracts requires further large-scale validation and research are planning to perform more tests on their novel high Cannabidiol C. Sativa lines. For instance, the testing results also showed that the extracts could potentially be used in a mouthwash or “throat gargle” to prevent COVID-19 infection.

Growing demand for legalization of medical and adult use of cannabis across the country

Growing demand for legalization of medical and adult use of cannabis will be the major factor driving the U.S. cannabis testing market revenue. Various government organizations and private players are recognizing the commercial and social importance of legalized medical and recreational cannabis. Moreover, various insurance companies are providing reimbursement for prescription of medical cannabis in states that have legalized the use of medical cannabis. For instance, the number of states in the U.S. that have legalized or decriminalized the use of medical marijuana has reached 36 as of November 2020. Similarly, 16 states across U.S. have either legalized or decriminalized the use of marijuana for recreational purposes.

Lack of uniform testing standards may hamper market growth in the United States

Stringent regulatory and quality control standards are required for administering accurate and precise dose of cannabis for both medical and recreational purposes may hinder the industry expansion. However, there is a lack of uniformity in quality standards across various states. For instance, there are different laws and variations regulating the testing standard of cannabis in different states of the U.S. These state laws define different possession limit. Considerable difference in laws regulating the use of medical and adult use of cannabis pose a significant challenge for testing laboratories to perform the quality assessment of these products.

Various advantages associated with chromatographic technique will fuel the market demand

U.S. Cannabis Testing Market By Technology

Get more details on this report - Request Free Sample PDF

The chromatography segment accounted for U.S. cannabis testing market share of 63.4% in 2020 due to various advantages associated with chromatography technique such as high sensitivity and ease of separation. Moreover, launch of technologically advanced equipment for performing various analytical and quality tests of cannabis will positively affect the chromatography segment growth. Furthermore, chromatography is generally used for testing potency of cannabis. The test ensures customer safety from harmful chemicals and contaminants. Thus, with growing demand of cannabis for medical and recreational use, new opportunities will arise for greater demand of such analytical instruments.

Pesticides are one of the important group of substances that must be tested before using cannabis

The pesticide testing segment size exceeded USD 390 million in 2020. Pesticides are one of the important group of substances that must be tested before using cannabis. The main objective of pesticide screening is to ensure the quality of cannabis products treated with pest control products. The screening or test should meet the requirements of the Pest Control Products Act and the Cannabis Act associated with the use of pest control products. The pesticide screening test is mandatory for the testing of unauthorized pest control products before the products could be sold or provided to the company. Furthermore, LC–MS is method of choice for pesticide analysis because of its selectivity, sensitivity, and ruggedness.

Growing number of testing laboratories and increasing use of medical & recreational marijuana in the Pacific Central zone

U.S. Cannabis Testing Maret By Zone

Get more details on this report - Request Free Sample PDF

Cannabis testing market revenue in Pacific Central zone was over USD 916.7 million in 2020 and is expected to witness growth of 8.2% through 2027 owing to growing number of testing laboratories in the zone. Additionally, presence of large number of cannabis patients in states such as Alaska, Hawaii, and California will further foster the market growth. Alaska & California have also approved the use of recreational marijuana leading to a rise in number of cannabis users. This will propel the demand for medical and recreational marijuana in the zone. Also, high demand for quality control and analytical testing of medical and adult-use cannabis in the Pacific Central zone will impel the market size expansion.

Adoption of various business strategies will provide new growth avenues for companies operating in the market

Notable players operating in the U.S. cannabis testing industry include Anresco, CannaSafe, Collective Wellness of California, Digipath, Inc, EVIO, Inc., PSI Labs, Steep Hill, Inc., SC Labs, Inc. Business expansion, product launch & approval and partnerships are the most adopted business strategies to sustain market competition.

The U.S. cannabis testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Technology

  • Chromatography
    • Liquid chromatography
    • Gas chromatography
    • Others
  • Spectroscopy
    • Mass spectroscopy
    • Atomic spectroscopy

Market, By Test Type

  • Potency testing
  • Pesticide screening
  • Residual solvent screening
  • Heavy metal testing
  • Terpene testing
  • Mycotoxin testing
  • Others

The above information is provided for the following zones and states:

  • North East
    • Connecticut
    • Maine
    • Massachusetts
    • New Hampshire
    • Rhode Island
    • Vermont
    • New Jersey
    • New York
    • Pennsylvania
  • East North Central
    • Illinois
    • Michigan
    • Ohio 
  • South Atlantic
    • Delaware
    • Florida
    • Maryland
    • Washington D.C.
  • West North Central
    • Minnesota
  • Pacific Central
    • Alaska
    • California
    • Hawaii
    • Oregon
    • Washington
  • Mountain States
    • Arizona
    • Colorado
    • Nevada
    • New Mexico
    • Montana
    • Utah
  • West South Central
    • Arkansas
    • Louisiana
    • Oklahoma


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The U.S. industry size for cannabis testing was pegged at USD 2 billion in value during 2020 and will expand at around 10.4% CAGR up to 2027, with increasing need to ensure quality control of hemp products.

The chromatography technology segment in the U.S. held around 63.4% market share in 2020 and will see high demand owing to benefits like ease of separation, high sensitivity, and access to advanced testing equipment.

The pesticide testing segment had reached USD 390 million revenue in 2020 due to the focus on meeting quality requirements and mandatory screening for unauthorized pest control substances.

The market size in Pacific Central zone was more than USD 916.7 million in 2020 and is projected to record a CAGR of 8.2% between 2020-2027.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2020
  • Companies covered: 10
  • Tables & Figures: 366
  • Countries covered: 31
  • Pages: 290

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount